AKEBIA THERAPEUTICS INC (AKBA) Stock Institutional Trading Activity


AKEBIA THERAPEUTICS INC (AKBA) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC, Baupost Group, and Abrams Capital Management. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2025Renaissance Technologies LLCSell-359,5943,593,133$5,784,944
Q3 2025Renaissance Technologies LLCSell-241,7003,952,727$10,790,945
Q2 2025Renaissance Technologies LLCBuy188,6004,194,427$15,267,714
Q1 2025Renaissance Technologies LLCBuy182,3004,005,827$7,691,188
Q4 2024Renaissance Technologies LLCBuy105,7273,823,527$7,264,701
Q3 2024Renaissance Technologies LLCSell-197,0003,717,800$4,907,496
Q2 2024Renaissance Technologies LLCBuy262,7003,914,800$3,993,096
Q1 2024Renaissance Technologies LLCSell-1,127,2833,652,100$6,683
Q4 2023Renaissance Technologies LLCBuy1,623,9564,779,383$5,926
Q3 2023Renaissance Technologies LLCSell-175,3003,155,427$3,597
Q2 2023Renaissance Technologies LLCBuy992,2273,330,727$3,048
Q1 2023Renaissance Technologies LLCSell-547,7272,338,500$1,310
Q4 2022Renaissance Technologies LLCSell-130,2002,886,227$1,665
Q3 2022Renaissance Technologies LLCBuy1,534,1273,016,427$954
Q2 2022Renaissance Technologies LLCBuy478,9731,482,300$523
Q1 2022Renaissance Technologies LLCBuy380,3001,003,327$720
Q4 2021Renaissance Technologies LLCSell-326,900623,027$1,408
Q3 2021Renaissance Technologies LLCSell-877,803949,927$2,736
Q2 2021Renaissance Technologies LLCBuy757,1491,827,730$6,927
Q1 2021Renaissance Technologies LLCSell-377,3461,070,581$3,624
Q4 2020Renaissance Technologies LLCBuy1,377,7521,447,927$4,054
Q3 2020Renaissance Technologies LLCSell-5,51470,175$176
Q2 2020Renaissance Technologies LLCSell-62,83875,689$1,028
Q2 2020Baupost GroupSell-2,527,96815,000,000$203,700
Q1 2020Baupost GroupSell-2,043,48517,527,968$132,862
Q4 2019Renaissance Technologies LLCBuy95,100138,527$875
Q4 2019Baupost GroupSell-4,900,00019,571,453$123,692
Q3 2019Renaissance Technologies LLCSell-1,733,54443,427$170
Q4 2018Abrams Capital ManagementBuy4,537,1765,656,462$31,280
Q4 2018Baupost GroupBuy24,471,45324,471,453$135,327

Frequently asked questions about AKBA activity

  • Which institutional owners are buying AKBA?

    Institutional owners buying AKBA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in AKBA activity?

    "Buy" means an investor increased their reported position in AKBA compared to the prior reporting period. This reflects growing exposure to AKEBIA THERAPEUTICS INC (AKBA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in AKBA increasing?

    Institutional interest in AKBA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.